dr. jonathan trent on pembrolizumab in advanced sarcomas
Published 8 years ago • 309 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
1:09
dr. jonathan trent on t- cell therapy in sarcoma
-
1:16
dr. jonathan trent on fda approval of trabectedin for soft tissue sarcomas
-
1:06
dr. trent on research efforts in bone and soft tissue sarcomas
-
0:55
jonathan trent on trabectedin for soft tissue sarcoma
-
0:54
dr. trent on the role of ctdna in soft tissue sarcoma
-
49:02
sarc talk episode 11 - dr. jonathan trent - pecoma
-
14:46
jonathan trent: energy from floating algae pods
-
20:31
soft tissue sarcoma | dr. talebi discusses "what is the treatment of stage 1 to 3 sarcoma?"
-
4:16
tavr patient testimonial: john o'connor
-
1:42
efficacy of pembrolizumab in multiple subtypes of sarcoma
-
2:13
dr. jon trent discusses his top picks on the use of immunotherapy in sarcomas during #asco20
-
1:28
jonathan c. trent, md, phd: principle treatment goals for this patient
-
1:14
dr. wilky on pembrolizumab plus axitinib in sarcoma
-
1:00
jonathan c. trent, md, phd: pattern of this patient’s metastatic disease
-
3:28
dr. jonathan trent, identification of genetic alterations by circulating tumor dna in leiomyosarcoma
-
1:30
dr. trent on sequencing trabectedin for patients with soft tissue sarcoma
-
4:10
advanced soft tissue sarcoma—incidence and subtypes
-
0:54
jonathan c. trent, md, phd: clinical data supporting the use of trabectedin
-
5:40
the future of treatment for soft tissue diseases
-
8:14
efficacy and toxicities with trabectedin in sarcomas
-
0:56
dr. wilky on ongoing trial of pembrolizumab and axitinib in sarcoma
-
1:28
dr. tolcher on utomilumab plus pembrolizumab in advanced solid tumors